Payoneer Global Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Payoneer Global Inc trades at $7.19 (market cap $2.43B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is the larger of the two by market cap, and Payoneer Global Inc is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Payoneer Global Inc for 61 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PAYO | RLAY | |
|---|---|---|
Market Cap | $2.43B | $3.82B |
Volume | 1,342,701 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $7.18 | $20.75 |
52-Week Low | $4.27 | $6.03 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $2.17B | $2.93B |
Signals from Pluang's Aura AI — not financial advice
Payoneer (PAYO) trades at $7.16, up 0.14% on the day, with a bullish technical signal from moving averages and a mixed earnings history including a Q2 2026 miss. Revenue grew to $821.16M in 2025, but net income declined to $73.19M, compressing margins. The company renewed its partnership with Etsy through 2029 and faces ongoing legal scrutiny regarding its proposed acquisition by Nuvei.
The outlook is cautious; while analyst consensus is 60% buy-rated and cash flow trends are positive, risks include earnings volatility, acquisition uncertainty, and competitive pressures. Investors should weigh strong institutional interest against execution challenges and margin pressures for medium-term growth.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →